0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Nicotine Replacement Therapy for Smoking Cessation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: December 2024
|
Report Code: QYRE-Auto-16P18632
Home | Market Reports | Sensitive Subjects
Nicotine Replacement Therapy for Smoking Cessation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
BUY CHAPTERS

Nicotine Replacement Therapy for Smoking Cessation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-16P18632
Report
December 2024
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nicotine Replacement Therapy for Smoking Cessation - Market Size

The global market for Nicotine Replacement Therapy for Smoking Cessation was estimated to be worth US$ 524 million in 2023 and is forecast to a readjusted size of US$ 727.3 million by 2030 with a CAGR of 4.8% during the forecast period 2024-2030

Nicotine Replacement Therapy for Smoking Cessation - Market

Nicotine Replacement Therapy for Smoking Cessation - Market

NRT, or Nicotine Replacement Therapy, refers to a range of smoking cessation aids that are designed to help individuals quit smoking by providing them with controlled doses of nicotine. NRT products are available in various forms, such as nicotine gum, patches, lozenges, nasal sprays, and inhalers. These aids work by delivering nicotine to the body without the harmful toxins and chemicals found in tobacco smoke, thereby reducing withdrawal symptoms and cravings associated with quitting smoking.
North American market for Nicotine Replacement Therapy for Smoking Cessation was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nicotine Replacement Therapy for Smoking Cessation was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Nicotine Replacement Therapy for Smoking Cessation was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Nicotine Replacement Therapy for Smoking Cessation include Pfizer, Cipla, Novartis, GlaxoSmithKline, Johnson & Johnson, Philip Morris, Perrigo Company, Alkalon and Ventus Medical, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nicotine Replacement Therapy for Smoking Cessation, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Nicotine Replacement Therapy for Smoking Cessation by region & country, by Type, and by Application.
The Nicotine Replacement Therapy for Smoking Cessation market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicotine Replacement Therapy for Smoking Cessation.
Market Segmentation

Scope of Nicotine Replacement Therapy for Smoking Cessation - Market Report

Report Metric Details
Report Name Nicotine Replacement Therapy for Smoking Cessation - Market
Forecasted market size in 2030 US$ 727.3 million
CAGR 4.8%
Forecasted years 2024 - 2030
Segment by Type:
  • Sprays and Inhalers
  • Gums
  • Patches
  • Lozenges
Segment by Application
  • Pharmacy
  • Supermarket
  • Hospital
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Cipla, Novartis, GlaxoSmithKline, Johnson & Johnson, Philip Morris, Perrigo Company, Alkalon, Ventus Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Nicotine Replacement Therapy for Smoking Cessation manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Nicotine Replacement Therapy for Smoking Cessation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Nicotine Replacement Therapy for Smoking Cessation in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Nicotine Replacement Therapy for Smoking Cessation - Market size in 2030?

Ans: The Nicotine Replacement Therapy for Smoking Cessation - Market size in 2030 will be US$ 727.3 million.

Who are the main players in the Nicotine Replacement Therapy for Smoking Cessation - Market report?

Ans: The main players in the Nicotine Replacement Therapy for Smoking Cessation - Market are Pfizer, Cipla, Novartis, GlaxoSmithKline, Johnson & Johnson, Philip Morris, Perrigo Company, Alkalon, Ventus Medical

What are the Application segmentation covered in the Nicotine Replacement Therapy for Smoking Cessation - Market report?

Ans: The Applications covered in the Nicotine Replacement Therapy for Smoking Cessation - Market report are Pharmacy, Supermarket, Hospital, Other

What are the Type segmentation covered in the Nicotine Replacement Therapy for Smoking Cessation - Market report?

Ans: The Types covered in the Nicotine Replacement Therapy for Smoking Cessation - Market report are Sprays and Inhalers, Gums, Patches, Lozenges

1 Market Overview
1.1 Nicotine Replacement Therapy for Smoking Cessation Product Introduction
1.2 Global Nicotine Replacement Therapy for Smoking Cessation Market Size Forecast
1.3 Nicotine Replacement Therapy for Smoking Cessation Market Trends & Drivers
1.3.1 Nicotine Replacement Therapy for Smoking Cessation Industry Trends
1.3.2 Nicotine Replacement Therapy for Smoking Cessation Market Drivers & Opportunity
1.3.3 Nicotine Replacement Therapy for Smoking Cessation Market Challenges
1.3.4 Nicotine Replacement Therapy for Smoking Cessation Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Nicotine Replacement Therapy for Smoking Cessation Players Revenue Ranking (2023)
2.2 Global Nicotine Replacement Therapy for Smoking Cessation Revenue by Company (2019-2024)
2.3 Key Companies Nicotine Replacement Therapy for Smoking Cessation Manufacturing Base Distribution and Headquarters
2.4 Key Companies Nicotine Replacement Therapy for Smoking Cessation Product Offered
2.5 Key Companies Time to Begin Mass Production of Nicotine Replacement Therapy for Smoking Cessation
2.6 Nicotine Replacement Therapy for Smoking Cessation Market Competitive Analysis
2.6.1 Nicotine Replacement Therapy for Smoking Cessation Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Nicotine Replacement Therapy for Smoking Cessation Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotine Replacement Therapy for Smoking Cessation as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Sprays and Inhalers
3.1.2 Gums
3.1.3 Patches
3.1.4 Lozenges
3.2 Global Nicotine Replacement Therapy for Smoking Cessation Sales Value by Type
3.2.1 Global Nicotine Replacement Therapy for Smoking Cessation Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Nicotine Replacement Therapy for Smoking Cessation Sales Value, by Type (2019-2030)
3.2.3 Global Nicotine Replacement Therapy for Smoking Cessation Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmacy
4.1.2 Supermarket
4.1.3 Hospital
4.1.4 Other
4.2 Global Nicotine Replacement Therapy for Smoking Cessation Sales Value by Application
4.2.1 Global Nicotine Replacement Therapy for Smoking Cessation Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Nicotine Replacement Therapy for Smoking Cessation Sales Value, by Application (2019-2030)
4.2.3 Global Nicotine Replacement Therapy for Smoking Cessation Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Nicotine Replacement Therapy for Smoking Cessation Sales Value by Region
5.1.1 Global Nicotine Replacement Therapy for Smoking Cessation Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Nicotine Replacement Therapy for Smoking Cessation Sales Value by Region (2019-2024)
5.1.3 Global Nicotine Replacement Therapy for Smoking Cessation Sales Value by Region (2025-2030)
5.1.4 Global Nicotine Replacement Therapy for Smoking Cessation Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Nicotine Replacement Therapy for Smoking Cessation Sales Value, 2019-2030
5.2.2 North America Nicotine Replacement Therapy for Smoking Cessation Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Nicotine Replacement Therapy for Smoking Cessation Sales Value, 2019-2030
5.3.2 Europe Nicotine Replacement Therapy for Smoking Cessation Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Nicotine Replacement Therapy for Smoking Cessation Sales Value, 2019-2030
5.4.2 Asia Pacific Nicotine Replacement Therapy for Smoking Cessation Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Nicotine Replacement Therapy for Smoking Cessation Sales Value, 2019-2030
5.5.2 South America Nicotine Replacement Therapy for Smoking Cessation Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Nicotine Replacement Therapy for Smoking Cessation Sales Value, 2019-2030
5.6.2 Middle East & Africa Nicotine Replacement Therapy for Smoking Cessation Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Nicotine Replacement Therapy for Smoking Cessation Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Nicotine Replacement Therapy for Smoking Cessation Sales Value
6.3 United States
6.3.1 United States Nicotine Replacement Therapy for Smoking Cessation Sales Value, 2019-2030
6.3.2 United States Nicotine Replacement Therapy for Smoking Cessation Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Nicotine Replacement Therapy for Smoking Cessation Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Nicotine Replacement Therapy for Smoking Cessation Sales Value, 2019-2030
6.4.2 Europe Nicotine Replacement Therapy for Smoking Cessation Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Nicotine Replacement Therapy for Smoking Cessation Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Nicotine Replacement Therapy for Smoking Cessation Sales Value, 2019-2030
6.5.2 China Nicotine Replacement Therapy for Smoking Cessation Sales Value by Type (%), 2023 VS 2030
6.5.3 China Nicotine Replacement Therapy for Smoking Cessation Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Nicotine Replacement Therapy for Smoking Cessation Sales Value, 2019-2030
6.6.2 Japan Nicotine Replacement Therapy for Smoking Cessation Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Nicotine Replacement Therapy for Smoking Cessation Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Nicotine Replacement Therapy for Smoking Cessation Sales Value, 2019-2030
6.7.2 South Korea Nicotine Replacement Therapy for Smoking Cessation Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Nicotine Replacement Therapy for Smoking Cessation Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Nicotine Replacement Therapy for Smoking Cessation Sales Value, 2019-2030
6.8.2 Southeast Asia Nicotine Replacement Therapy for Smoking Cessation Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Nicotine Replacement Therapy for Smoking Cessation Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Nicotine Replacement Therapy for Smoking Cessation Sales Value, 2019-2030
6.9.2 India Nicotine Replacement Therapy for Smoking Cessation Sales Value by Type (%), 2023 VS 2030
6.9.3 India Nicotine Replacement Therapy for Smoking Cessation Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Profile
7.1.2 Pfizer Main Business
7.1.3 Pfizer Nicotine Replacement Therapy for Smoking Cessation Products, Services and Solutions
7.1.4 Pfizer Nicotine Replacement Therapy for Smoking Cessation Revenue (US$ Million) & (2019-2024)
7.1.5 Pfizer Recent Developments
7.2 Cipla
7.2.1 Cipla Profile
7.2.2 Cipla Main Business
7.2.3 Cipla Nicotine Replacement Therapy for Smoking Cessation Products, Services and Solutions
7.2.4 Cipla Nicotine Replacement Therapy for Smoking Cessation Revenue (US$ Million) & (2019-2024)
7.2.5 Cipla Recent Developments
7.3 Novartis
7.3.1 Novartis Profile
7.3.2 Novartis Main Business
7.3.3 Novartis Nicotine Replacement Therapy for Smoking Cessation Products, Services and Solutions
7.3.4 Novartis Nicotine Replacement Therapy for Smoking Cessation Revenue (US$ Million) & (2019-2024)
7.3.5 GlaxoSmithKline Recent Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Profile
7.4.2 GlaxoSmithKline Main Business
7.4.3 GlaxoSmithKline Nicotine Replacement Therapy for Smoking Cessation Products, Services and Solutions
7.4.4 GlaxoSmithKline Nicotine Replacement Therapy for Smoking Cessation Revenue (US$ Million) & (2019-2024)
7.4.5 GlaxoSmithKline Recent Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Profile
7.5.2 Johnson & Johnson Main Business
7.5.3 Johnson & Johnson Nicotine Replacement Therapy for Smoking Cessation Products, Services and Solutions
7.5.4 Johnson & Johnson Nicotine Replacement Therapy for Smoking Cessation Revenue (US$ Million) & (2019-2024)
7.5.5 Johnson & Johnson Recent Developments
7.6 Philip Morris
7.6.1 Philip Morris Profile
7.6.2 Philip Morris Main Business
7.6.3 Philip Morris Nicotine Replacement Therapy for Smoking Cessation Products, Services and Solutions
7.6.4 Philip Morris Nicotine Replacement Therapy for Smoking Cessation Revenue (US$ Million) & (2019-2024)
7.6.5 Philip Morris Recent Developments
7.7 Perrigo Company
7.7.1 Perrigo Company Profile
7.7.2 Perrigo Company Main Business
7.7.3 Perrigo Company Nicotine Replacement Therapy for Smoking Cessation Products, Services and Solutions
7.7.4 Perrigo Company Nicotine Replacement Therapy for Smoking Cessation Revenue (US$ Million) & (2019-2024)
7.7.5 Perrigo Company Recent Developments
7.8 Alkalon
7.8.1 Alkalon Profile
7.8.2 Alkalon Main Business
7.8.3 Alkalon Nicotine Replacement Therapy for Smoking Cessation Products, Services and Solutions
7.8.4 Alkalon Nicotine Replacement Therapy for Smoking Cessation Revenue (US$ Million) & (2019-2024)
7.8.5 Alkalon Recent Developments
7.9 Ventus Medical
7.9.1 Ventus Medical Profile
7.9.2 Ventus Medical Main Business
7.9.3 Ventus Medical Nicotine Replacement Therapy for Smoking Cessation Products, Services and Solutions
7.9.4 Ventus Medical Nicotine Replacement Therapy for Smoking Cessation Revenue (US$ Million) & (2019-2024)
7.9.5 Ventus Medical Recent Developments
8 Industry Chain Analysis
8.1 Nicotine Replacement Therapy for Smoking Cessation Industrial Chain
8.2 Nicotine Replacement Therapy for Smoking Cessation Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Nicotine Replacement Therapy for Smoking Cessation Sales Model
8.5.2 Sales Channel
8.5.3 Nicotine Replacement Therapy for Smoking Cessation Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Nicotine Replacement Therapy for Smoking Cessation Market Trends
    Table 2. Nicotine Replacement Therapy for Smoking Cessation Market Drivers & Opportunity
    Table 3. Nicotine Replacement Therapy for Smoking Cessation Market Challenges
    Table 4. Nicotine Replacement Therapy for Smoking Cessation Market Restraints
    Table 5. Global Nicotine Replacement Therapy for Smoking Cessation Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Nicotine Replacement Therapy for Smoking Cessation Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Nicotine Replacement Therapy for Smoking Cessation Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Nicotine Replacement Therapy for Smoking Cessation Product Type
    Table 9. Key Companies Time to Begin Mass Production of Nicotine Replacement Therapy for Smoking Cessation
    Table 10. Global Nicotine Replacement Therapy for Smoking Cessation Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotine Replacement Therapy for Smoking Cessation as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Nicotine Replacement Therapy for Smoking Cessation Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Nicotine Replacement Therapy for Smoking Cessation Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Nicotine Replacement Therapy for Smoking Cessation Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Nicotine Replacement Therapy for Smoking Cessation Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Nicotine Replacement Therapy for Smoking Cessation Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Nicotine Replacement Therapy for Smoking Cessation Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Nicotine Replacement Therapy for Smoking Cessation Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Nicotine Replacement Therapy for Smoking Cessation Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Nicotine Replacement Therapy for Smoking Cessation Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Nicotine Replacement Therapy for Smoking Cessation Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Nicotine Replacement Therapy for Smoking Cessation Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Nicotine Replacement Therapy for Smoking Cessation Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Nicotine Replacement Therapy for Smoking Cessation Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Nicotine Replacement Therapy for Smoking Cessation Sales Value by Region (2019-2024) & (%)
    Table 27. Global Nicotine Replacement Therapy for Smoking Cessation Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Nicotine Replacement Therapy for Smoking Cessation Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Nicotine Replacement Therapy for Smoking Cessation Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Nicotine Replacement Therapy for Smoking Cessation Sales Value, (2025-2030) & (US$ Million)
    Table 31. Pfizer Basic Information List
    Table 32. Pfizer Description and Business Overview
    Table 33. Pfizer Nicotine Replacement Therapy for Smoking Cessation Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Nicotine Replacement Therapy for Smoking Cessation Business of Pfizer (2019-2024)
    Table 35. Pfizer Recent Developments
    Table 36. Cipla Basic Information List
    Table 37. Cipla Description and Business Overview
    Table 38. Cipla Nicotine Replacement Therapy for Smoking Cessation Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Nicotine Replacement Therapy for Smoking Cessation Business of Cipla (2019-2024)
    Table 40. Cipla Recent Developments
    Table 41. Novartis Basic Information List
    Table 42. Novartis Description and Business Overview
    Table 43. Novartis Nicotine Replacement Therapy for Smoking Cessation Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Nicotine Replacement Therapy for Smoking Cessation Business of Novartis (2019-2024)
    Table 45. Novartis Recent Developments
    Table 46. GlaxoSmithKline Basic Information List
    Table 47. GlaxoSmithKline Description and Business Overview
    Table 48. GlaxoSmithKline Nicotine Replacement Therapy for Smoking Cessation Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Nicotine Replacement Therapy for Smoking Cessation Business of GlaxoSmithKline (2019-2024)
    Table 50. GlaxoSmithKline Recent Developments
    Table 51. Johnson & Johnson Basic Information List
    Table 52. Johnson & Johnson Description and Business Overview
    Table 53. Johnson & Johnson Nicotine Replacement Therapy for Smoking Cessation Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Nicotine Replacement Therapy for Smoking Cessation Business of Johnson & Johnson (2019-2024)
    Table 55. Johnson & Johnson Recent Developments
    Table 56. Philip Morris Basic Information List
    Table 57. Philip Morris Description and Business Overview
    Table 58. Philip Morris Nicotine Replacement Therapy for Smoking Cessation Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Nicotine Replacement Therapy for Smoking Cessation Business of Philip Morris (2019-2024)
    Table 60. Philip Morris Recent Developments
    Table 61. Perrigo Company Basic Information List
    Table 62. Perrigo Company Description and Business Overview
    Table 63. Perrigo Company Nicotine Replacement Therapy for Smoking Cessation Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Nicotine Replacement Therapy for Smoking Cessation Business of Perrigo Company (2019-2024)
    Table 65. Perrigo Company Recent Developments
    Table 66. Alkalon Basic Information List
    Table 67. Alkalon Description and Business Overview
    Table 68. Alkalon Nicotine Replacement Therapy for Smoking Cessation Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Nicotine Replacement Therapy for Smoking Cessation Business of Alkalon (2019-2024)
    Table 70. Alkalon Recent Developments
    Table 71. Ventus Medical Basic Information List
    Table 72. Ventus Medical Description and Business Overview
    Table 73. Ventus Medical Nicotine Replacement Therapy for Smoking Cessation Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Nicotine Replacement Therapy for Smoking Cessation Business of Ventus Medical (2019-2024)
    Table 75. Ventus Medical Recent Developments
    Table 76. Key Raw Materials Lists
    Table 77. Raw Materials Key Suppliers Lists
    Table 78. Nicotine Replacement Therapy for Smoking Cessation Downstream Customers
    Table 79. Nicotine Replacement Therapy for Smoking Cessation Distributors List
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
    Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Nicotine Replacement Therapy for Smoking Cessation Product Picture
    Figure 2. Global Nicotine Replacement Therapy for Smoking Cessation Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Nicotine Replacement Therapy for Smoking Cessation Sales Value (2019-2030) & (US$ Million)
    Figure 4. Nicotine Replacement Therapy for Smoking Cessation Report Years Considered
    Figure 5. Global Nicotine Replacement Therapy for Smoking Cessation Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Nicotine Replacement Therapy for Smoking Cessation Revenue in 2023
    Figure 7. Nicotine Replacement Therapy for Smoking Cessation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Sprays and Inhalers Picture
    Figure 9. Gums Picture
    Figure 10. Patches Picture
    Figure 11. Lozenges Picture
    Figure 12. Global Nicotine Replacement Therapy for Smoking Cessation Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Nicotine Replacement Therapy for Smoking Cessation Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Pharmacy
    Figure 15. Product Picture of Supermarket
    Figure 16. Product Picture of Hospital
    Figure 17. Product Picture of Other
    Figure 18. Global Nicotine Replacement Therapy for Smoking Cessation Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Nicotine Replacement Therapy for Smoking Cessation Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America Nicotine Replacement Therapy for Smoking Cessation Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America Nicotine Replacement Therapy for Smoking Cessation Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe Nicotine Replacement Therapy for Smoking Cessation Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe Nicotine Replacement Therapy for Smoking Cessation Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific Nicotine Replacement Therapy for Smoking Cessation Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific Nicotine Replacement Therapy for Smoking Cessation Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America Nicotine Replacement Therapy for Smoking Cessation Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America Nicotine Replacement Therapy for Smoking Cessation Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa Nicotine Replacement Therapy for Smoking Cessation Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa Nicotine Replacement Therapy for Smoking Cessation Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions Nicotine Replacement Therapy for Smoking Cessation Sales Value (%), (2019-2030)
    Figure 31. United States Nicotine Replacement Therapy for Smoking Cessation Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States Nicotine Replacement Therapy for Smoking Cessation Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States Nicotine Replacement Therapy for Smoking Cessation Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe Nicotine Replacement Therapy for Smoking Cessation Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe Nicotine Replacement Therapy for Smoking Cessation Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe Nicotine Replacement Therapy for Smoking Cessation Sales Value by Application (%), 2023 VS 2030
    Figure 37. China Nicotine Replacement Therapy for Smoking Cessation Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China Nicotine Replacement Therapy for Smoking Cessation Sales Value by Type (%), 2023 VS 2030
    Figure 39. China Nicotine Replacement Therapy for Smoking Cessation Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan Nicotine Replacement Therapy for Smoking Cessation Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan Nicotine Replacement Therapy for Smoking Cessation Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan Nicotine Replacement Therapy for Smoking Cessation Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea Nicotine Replacement Therapy for Smoking Cessation Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea Nicotine Replacement Therapy for Smoking Cessation Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea Nicotine Replacement Therapy for Smoking Cessation Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia Nicotine Replacement Therapy for Smoking Cessation Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Nicotine Replacement Therapy for Smoking Cessation Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia Nicotine Replacement Therapy for Smoking Cessation Sales Value by Application (%), 2023 VS 2030
    Figure 49. India Nicotine Replacement Therapy for Smoking Cessation Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India Nicotine Replacement Therapy for Smoking Cessation Sales Value by Type (%), 2023 VS 2030
    Figure 51. India Nicotine Replacement Therapy for Smoking Cessation Sales Value by Application (%), 2023 VS 2030
    Figure 52. Nicotine Replacement Therapy for Smoking Cessation Industrial Chain
    Figure 53. Nicotine Replacement Therapy for Smoking Cessation Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS